Isidro Mª Luisa, Cordido Fernando
Endocrine Department, Complejo Hospitalario Universitario A Coruña As Xubias 84, 15006 A Coruña, Spain.
Pharmaceuticals (Basel). 2010 Jan 12;3(1):125-145. doi: 10.3390/ph3010125.
Available anti-obesity pharmacotherapy options remain very limited and development of more effective drugs has become a priority. The potential strategies to achieve weight loss are to reduce energy intake by stimulating anorexigenic signals or by blocking orexigenic signals, and to increase energy expenditure. This review will focus on approved obesity medications, as well as potential new pharmacologic treatment options.
现有的抗肥胖药物治疗选择仍然非常有限，开发更有效的药物已成为当务之急。实现体重减轻的潜在策略是通过刺激厌食信号或阻断食欲信号来减少能量摄入，以及增加能量消耗。本综述将重点关注已获批的肥胖症药物以及潜在的新药物治疗选择。
